Piper Jaffray Raises INFI Target From $6 To $9, Upgrades Shares To OW

May 9, 2011 7:22 AM | 10 seconds read |
Piper Jaffray is upgrading shares of Infinity Pharmaceuticals, Inc. INFI from Neutral to Overweight while raising its PT from $6 to $9. Infinity Pharmaceuticals closed Friday at $5.79.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: UpgradesPrice TargetAnalyst RatingsBiotechnologyHealth CareInfinity PharmaceuticalsPiper Jaffray
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!